SUZB3:BMFBOVESPASuzano S.A. Analysis
Data as of 2026-06-14 - not real-time
R$41.52
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Suzano (SUZB3) is trading at R$41.52, just below its 20‑day SMA (R$41.60) and well under the 50‑day (R$44.36) and 200‑day (R$49.38) averages, indicating a short‑term bearish bias but a longer‑term downtrend. Technical support at R$40.17 and resistance near R$43 suggest a relatively tight range, while the MACD histogram turning positive and the “bullish” MACD signal hint at a possible near‑term rebound. The stock’s valuation is strikingly cheap – a trailing P/E of ~4.5x, P/B of 1.17x, and a DCF‑derived fair value of roughly R$64, implying an upside of over 50% from current levels. Fundamentally, Suzano delivers strong profitability (ROE ~26%) and a modest dividend yield of 2.7% with a low payout ratio (~12%), but the balance sheet is heavily leveraged (debt‑to‑equity >200%) and free cash flow is negative, raising sustainability concerns. Volatility is elevated at ~22.7% over the past month, yet beta remains low (Given the sizable valuation gap, solid earnings power, and dividend appeal, the upside potential outweighs the near‑term technical weakness. However, investors should monitor debt reduction progress and cash‑flow trends, as these will be pivotal for long‑term stability. The combination of cheap multiples, attractive dividend, and strong analyst support makes Suzano a compelling buy for investors comfortable with moderate volatility and sector‑specific risks.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near technical support with bullish MACD signal
- Significant valuation upside versus DCF fair value
- Attractive dividend yield with low payout ratio
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong profitability metrics (ROE, margins)
- Analyst consensus of strong‑buy and high target prices
- Continued dividend income despite leverage
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Fundamental growth prospects in pulp and paper demand
- Potential debt deleveraging improving cash‑flow profile
- Long‑term valuation gap offering >50% upside
Key Metrics & Analysis
Financial Health
Revenue Growth-5.10%
Profit Margin22.96%
P/E Ratio4.5
ROE26.30%
ROA3.69%
Debt/Equity202.35
P/B Ratio1.2
Op. Cash FlowR$16.6B
Free Cash FlowR$-1823903104
Technical Analysis
TrendBearish
RSI42.0
SupportR$40.17
ResistanceR$43.00
MA 20R$41.60
MA 50R$44.36
MA 200R$49.38
MACDBullish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair ValueR$63.96
Target PriceR$65.66
Upside/Downside58.15%
GradeUndervalued
TypeBlend
Dividend Yield2.70%
Risk Assessment
Beta0.28
Volatility22.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.